Medspa
Aesthetic-medicine signals for medspa operators: devices, injectables, regulation, and the brand moves shaping the treatment room.
Reports available
48
SOCELLE reports currently available in this topic.
Operator question
What is changing in aesthetic treatments, regulation, and premium service delivery that a medspa operator should act on now?
Current published read
A Bronx NAD+ infusion death and fresh treatment-marketing signals put operator attention back on licensure, product provenance and claim boundaries.
Review the evidenceMedspa start here
This hub covers operator-facing market signals, not patient-specific treatment advice, medical diagnosis, or dosing guidance.
AI-assisted briefJul 28, 2026
A Bronx NAD+ infusion death and fresh treatment-marketing signals put operator attention back on licensure, product provenance and claim boundaries.
Start with this
The clearest current entry point for medspa readers.
Why this lane matters
What is changing in aesthetic treatments, regulation, and premium service delivery that a medspa operator should act on now?
Medspa reports
Each report keeps the analysis, date, and imagery together so the collection is easy to scan before you choose what to read.
Follow the market path
Medspa decision support
SOCELLE scopes the decision, evidence plan, caveats, and paid artifact before the work begins.
The intelligence digest
A focused weekly read of the reports, market shifts, and beauty business signals worth keeping close.
Free. No spam. Unsubscribe anytime. We use your details per our Privacy Policy and never sell them.
